sample product table

sample product

ExoQuick-TC

  • Sherman-Samis, M, et al. (2019) SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma. Gynecol. Oncol.. 2019 Mar 20;. PM ID: 30904337